News

CHEMISTREE COMPLETES INVESTMENT IN NEW JERSEY CANNABIS APPLICANT – ACS

Vancouver, British Columbia, July 22, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that through a wholly owned U.S. subsidiary, the Company has finalized its investment into Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical vertically integrated applicant, previously announced as a

Read More »

Chemistree Announces Resignation of Non-Executive Chairman

VANCOUVER, June 14, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), announces that Non-executive Chairman of the board, Justin Chorbajian has tendered his resignation. Company president Karl Kottmeier commented, “On behalf of the board I’d like to thank Justin for his contributions to the Company over the past twenty-two months, and we wish him well

Read More »

CHEMISTREE COMMENTS ON RECENT PROMOTIONAL ACTIVITY AT REQUEST OF OTC MARKETS

VANCOUVER, June 13, 2019 /CNW/ – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), has been requested by OTC Markets Group to comment on recent promotional activity. The Company first became aware of certain promotional third-party newsletter activities through a notification by OTC Markets on June 11, 2019. The Company takes its investor relations

Read More »

CHEMISTREE PARTNER, ACS, TO FILE NEW JERSEY APPLICATION UNDER NEW DOH MANDATE

Vancouver, British Columbia, June 10, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that its partner Applied Cannabis Sciences of New Jersey (“ACS”), is readying an Application under the new Request for Applications (RFA) program announced by the Department of Health on June 3, 2019.

Read More »

Chemistree Acquires Ownership Stake in The Physician’s Choice CBD LLC

– Doctor created, CBD from Hemp Pain Management Company VANCOUVER, April 29, 2019 – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a funding agreement with The Physician’s Choice CBD LLC of Phoenix, Arizona. The Physician’s Choice CBD (“PCCBD”) is dedicated to

Read More »

Chemistree Provides California and Washington Operations Update

VANCOUVER, April 18, 2019  – Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to provide shareholders with an update on the Company’s Washington State assets and its Desert Hot Springs, California cultivation facility development. Chemistree has received reports from its Washington state licensee partner that further advancements have been made in crucial areas of

Read More »

CHEMISTREE ANNOUNCES PARTNERSHIP WITH NEW JERSEY MEDICAL RETAIL CANNABIS LICENSE APPLICANT

Vancouver, British Columbia, April 15, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that its wholly owned U.S. subsidiary, American CHM Investments Inc., has signed a letter of intent (LOI) to partner with Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical retail

Read More »

CHEMISTREE APPOINTS NICO ESCONDIDO TO BOARD OF DIRECTORS

– HIGH TIMES OWNER & CHIEF CANNABIS OFFICER – FOUNDER OF THE CANNABIS GENETICS INSTITUTE – LEADING INDUSTRY RESEARCHER & EDUCATOR Vancouver, British Columbia, April 9, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce the appointment of Mr. Nicholas J. Zitelli to its Board of

Read More »

CHEMISTREE GRANTS STOCK OPTIONS – Restarts Digital Marketing Intiatives

Vancouver, British Columbia, April 5, 2019 – Chemistree Technology Inc. (Canadian Securities Exchange: CHM and CHM.WT) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) pursuant to the Company’s stock option plan — has granted options to purchase 1,300,000 common shares at $0.60 per share to certain eligible directors, officers and consultants. The options expire in five

Read More »

CHEMISTREE ANNOUNCES CLOSING OF PROSPECTUS OFFERING AND CONCURRENT PRIVATE PLACEMENT

Vancouver, British Columbia, March 29, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) announced today that it has closed its previously announced short form prospectus offering (the “Brokered Offering”) and concurrent private placement (the “Concurrent Private Placement”) of 10% unsecured debenture units (the “Debenture Units”) of the Company, for

Read More »
Scroll to Top